Palatal myoclonus and opioid peptides.
We report a patient who presented palatal myoclonus (PM) after anoxic brain damage that was completely abolished by the administration of opioid agonists. This suggests the involvement of peptide systems in the development of PM.
Martínez-Vila
E
E
Department of Neurology, Clínica Universitaria, Medical School, University of Navarra, Pamplona, Spain.
Martínez-Lage Alvarez
P
P
Luquin
M R
MR
Martínez-Lage
J M
JM
D002277:Carcinoma / Q000473:pathology / Q000601:surgery; D004723:Endorphins / Q000627:therapeutic use*; D015600:Glasgow Coma Scale; D006323:Heart Arrest / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007822:Laryngeal Neoplasms / Q000473:pathology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009119:Muscle Contraction; D009207:Myoclonus / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology*; D009270:Naloxone / Q000627:therapeutic use*; D010160:Palate, Soft / Q000503:physiopathology*
D004723:Endorphins; D009270:Naloxone